AL
IJK icon

Aspiriant LLC’s iShares S&P Mid-Cap 400 Growth ETF IJK Stock Holding History

Aspiriant LLC’s Portfolio IJK Stock Details IJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,670
Closed -$206K – 281
2022
Q1 		$206K Buy
+2,670
New +$206K 0.01% 264

Other funds holding IJK

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aspiriant LLC's IJK Position: Q2 2022 in Review

Aspiriant LLC sold out of iShares S&P Mid-Cap 400 Growth ETF (IJK) in Q2 2022, closing a stake of 2,670 shares — an estimated $206K sold.

Aspiriant LLC first reported a position in IJK in Q1 2022 and held it in 1 quarter. The position peaked at $206K in Q1 2022. 662 funds tracked by Wall St. Rank hold IJK as of Q2 2022.

  • Aspiriant LLC reported no remaining iShares S&P Mid-Cap 400 Growth ETF position as of Q2 2022 after selling out during the quarter.
  • Aspiriant LLC sold 2,670 iShares S&P Mid-Cap 400 Growth ETF shares in Q2 2022, an estimated $206K.
  • Aspiriant LLC first reported a position in iShares S&P Mid-Cap 400 Growth ETF in Q1 2022 and held it in 1 quarter.
  • Aspiriant LLC's iShares S&P Mid-Cap 400 Growth ETF position peaked at $206K in Q1 2022.
  • 662 funds tracked by Wall St. Rank held iShares S&P Mid-Cap 400 Growth ETF as of Q2 2022.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.